2-(Methylamino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile, 95.0%, 1g

1-Bromo-2-isopropyl-3,4-dimethoxybenzene, 97%, 500mg

2-(3-(4-Chloro-3-nitrophenyl)prop-2-enoylamino)benzamide, 95.0%, 1g

(S)-2-((tert-Butoxycarbonyl)(methyl)amino)pent-4-enoic acid, 97%, 1g

(25-35% Methylethylhydrosiloxane)-dimethylsiloxane copolymer, trimethylsiloxane terminated, reduced volatility, 100g

N-(4-methoxybenzyl)-1-(2-methoxyphenyl)methanamine hydrochloride, 95.0%, 5g

N,N-Diethylformamide, 98.0%, 1kg

1-Propylpiperidin-4-amine, 97%, 1g

(4-Hydroxyphenyl)(2,4,6-trihydroxyphenyl)methanone, 98%, 5mg

4-Pyridineacetic acid, 90.0%, 500mg

4-(methylthio)-1,3-benzothiazol-2-amine, 95.0%, 500mg

Methyl 1,5-Dimethyl-1H-pyrazole-3-carboxylate, 97.0%, 5g

2-Hydroxy-3-methylbenzonitrile, 95.0%, 10g